ARCHIVES

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Hammond Honored By ACS; SEER Celebrates 20th Anniversary With Symposium Dec. 8

December 3, 1993

HHS Appeals Board Finds No Misconduct By Popovic

November 12, 1993

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

Blackburn Wins BMS Award

May 23, 2003

NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor

June 19, 1987

Bernard Fisher Sues Univ. of Pittsburgh And Its Attorney

July 15, 1994